Overall, our results suggest that 7T MR‐derived measurements indicative of AD progression are reflected by plasma p‐tau181 and GFAP, while effects are not limited to brain changes in areas of early tau deposition or neuroinflammation measured by MRS myo‐inositol, respectively. Here, GFAP is linked to Alzheimer disease.